Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice

Abstract Purpose Sepsis is hallmarked by high plasma cortisol/corticosterone (CORT), low adrenocorticotropic hormone (ACTH), and high pro-opiomelanocortin (POMC). While corticotropin-releasing hormone-(CRH) and arginine-vasopressin (AVP)-driven pituitary POMC expression remains active, POMC processing into ACTH becomes impaired. Low ACTH is accompanied by loss of adrenocortical structure, although steroidogenic enzymes remain expressed. We hypothesized that treatment of sepsis with hydrocortisone (HC) aggravates this phenotype whereas CRH infusion safeguards ACTH-driven adrenocortical structure. Methods In a fluid-resuscitated, antibiotics-treated mouse model of prolonged sepsis, we compared the effects of HC and CRH infusion with placebo on plasma ACTH, POMC, and CORT; on markers of hypothalamic CRH and AVP signaling and pituitary POMC processing; and on the adrenocortical structure and markers of steroidogenesis. In adrenal explants, we studied the steroidogenic capacity of POMC. Results During sepsis, HC further suppressed plasma ACTH, but not POMC, predominantly by suppressing sepsis-activated CRH/AVP-signaling pathways. In contrast, in CRH-treated sepsis, plasma ACTH was normalized following restoration of pituitary POMC processing. The sepsis-induced rise in markers of adrenocortical steroidogenesis was unaltered by CRH and suppressed partially by HC, which also increased adrenal markers of inflammation. Ex vivo stimulation of adrenal explants with POMC increased CORT as effectively as an equimolar dose of ACTH. Conclusions Treatment of sepsis with HC impaired integrity and function of the hypothalamic-pituitary-adrenal axis at the level of the pituitary and the adrenal cortex while CRH restored pituitary POMC processing without affecting the adrenal cortex. Sepsis-induced high-circulating POMC may be responsible for ongoing adrenocortical steroidogenesis despite low ACTH.

[1]  D. Annane,et al.  Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis , 2021, Intensive Care Medicine.

[2]  G. Van den Berghe,et al.  The role of pro-opiomelanocortin in the ACTH–cortisol dissociation of sepsis , 2021, Critical Care.

[3]  J. Spencer-Segal,et al.  Glucocorticoids and the brain after critical illness. , 2021, Endocrinology.

[4]  S. Lightman,et al.  Prolonged treatment with the synthetic glucocorticoid methylprednisolone affects adrenal steroidogenic function and response to inflammatory stress in the rat , 2020, Brain, Behavior, and Immunity.

[5]  J. González-Martín,et al.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[6]  G. Van den Berghe,et al.  Adrenal function and dysfunction in critically ill patients , 2019, Nature Reviews Endocrinology.

[7]  Gavin D Perkins,et al.  Guidelines on the management of acute respiratory distress syndrome , 2019, BMJ Open Respiratory Research.

[8]  A. Coll,et al.  POMC: The Physiological Power of Hormone Processing. , 2018, Physiological reviews.

[9]  G. Van den Berghe,et al.  Adrenocortical function during prolonged critical illness and beyond: a prospective observational study , 2018, Intensive Care Medicine.

[10]  C. Deutschman,et al.  Cecal Ligation and Puncture Alters Glucocorticoid Receptor Expression , 2018, Critical care medicine.

[11]  E. Lindsay Hydrocortisone plus Fludrocortisone for Adults with Septic Shock , 2018, The Journal of Emergency Medicine.

[12]  G. Van den Berghe,et al.  The Hepatic Glucocorticoid Receptor Is Crucial for Cortisol Homeostasis and Sepsis Survival in Humans and Male Mice. , 2018, Endocrinology.

[13]  B. Souweine,et al.  Hydrocortisone plus Fludrocortisone for Adults with Septic Shock , 2018, The New England journal of medicine.

[14]  R. Bellomo,et al.  Adjunctive Glucocorticoid Therapy in Patients with Septic Shock , 2018, The New England journal of medicine.

[15]  G. Van den Berghe,et al.  Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 , 2018, Intensive Care Medicine.

[16]  P. Marik,et al.  Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) , 2017, Intensive Care Medicine.

[17]  G. Van den Berghe,et al.  Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness. , 2017, Journal of visualized experiments : JoVE.

[18]  Sangeeta Mehta,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[19]  M. Koçak,et al.  Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial , 2016, Critical Care.

[20]  W. Dixon,et al.  Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review , 2016, Seminars in arthritis and rheumatism.

[21]  S. O’Rahilly,et al.  PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders. , 2016, Endocrine reviews.

[22]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[23]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[24]  D. Angus,et al.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. , 2016, American journal of respiratory and critical care medicine.

[25]  M. Low,et al.  Rapid Glucocorticoid Feedback Inhibition of ACTH Secretion Involves Ligand-Dependent Membrane Association of Glucocorticoid Receptors. , 2015, Endocrinology.

[26]  O. Dekkers,et al.  [Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis]. , 2015, Nederlands tijdschrift voor geneeskunde.

[27]  G. Van den Berghe,et al.  Impact of duration of critical illness on the adrenal glands of human intensive care patients. , 2014, The Journal of clinical endocrinology and metabolism.

[28]  D. Needham,et al.  Corticosteroids and Transition to Delirium in Patients With Acute Lung Injury* , 2014, Critical care medicine.

[29]  G. Van den Berghe,et al.  Reduced cortisol metabolism during critical illness. , 2013, The New England journal of medicine.

[30]  S. Reber,et al.  Chronic psychosocial stress results in sensitization of the HPA axis to acute heterotypic stressors despite a reduction of adrenal in vitro ACTH responsiveness , 2012, Psychoneuroendocrinology.

[31]  Mike Hernandez,et al.  US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock. , 2012, Journal of critical care.

[32]  E. Marcantonio,et al.  Cognitive trajectories after postoperative delirium. , 2012, The New England journal of medicine.

[33]  J. Flanagan,et al.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.

[34]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[35]  K. Craig,et al.  Coding of facial expressions of pain in the laboratory mouse , 2010, Nature Methods.

[36]  S. Lamberts,et al.  Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis , 2009, Intensive Care Medicine.

[37]  C. Torres-Farfan,et al.  Rhythmic expression of functional MT1 melatonin receptors in the rat adrenal gland. , 2008, Endocrinology.

[38]  M. Christ-Crain,et al.  Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease , 2008, BMC pulmonary medicine.

[39]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[40]  R. Hubbard,et al.  Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study , 2006, Thorax.

[41]  M. Kéramidas,et al.  Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex. , 2004, Endocrinology.

[42]  Theodore Speroff,et al.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. , 2004, JAMA.

[43]  N. H. Steigbigel Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[44]  Gene expression of proprotein convertases in individual rat anterior pituitary cells and their regulation in corticotrophs mediated by glucocorticoids. , 2002, Endocrinology.

[45]  W. Huttner,et al.  Cholesterol is Required for the Formation of Regulated and Constitutive Secretory Vesicles from the trans‐Golgi Network , 2000, Traffic.

[46]  D. Swaab,et al.  Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. , 1998, The Journal of clinical endocrinology and metabolism.

[47]  L. Muglia,et al.  Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. , 1997, The Journal of clinical investigation.

[48]  N. Kalin,et al.  Effects of dexamethasone on central and peripheral ACTH systems in the rat. , 1987, Neuroendocrinology.

[49]  N. Birnberg,et al.  Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Corticosteroids and hypothalamic-pituitary-adrenocortical function. , 1980, British medical journal.

[51]  J. Gasson Steroidogenic activity of high molecular weight forms of corticotropin. , 1979, Biochemistry.

[52]  D. Lockwood,et al.  Pituitary adrenal recovery following short-term suppression with corticosteroids. , 1979, The American journal of medicine.